Doxazosin Tablet
Product Images NDC 0832-0356

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 0832-0356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Doxazosin 01)

Chemical structure of doxazosin mesylate shown as a molecular formula diagram with aromatic rings, nitrogen atoms, methoxy groups, and a methanesulfonic acid component as part of the mesylate salt.*

FDA Label Image

Table 3 (Doxazosin 02)

A combined data table and bar graph depicting the effects of Doxazosin on symptom score and maximum flow rate in three clinical studies. The table shows mean baseline and mean change values for symptom scores and flow rates comparing placebo, Doxazosin 4 mg, and 8 mg doses. The adjacent bar graph illustrates maximum flow rate and symptom score changes from Study 2, highlighting greater improvements with Doxazosin 4 mg and 8 mg compared to placebo.*

FDA Label Image

Figure 1 (Doxazosin 03)

Figure 1 from Study 1 presents two graphs showing the effects of Doxazosin versus placebo over a 14-week treatment period. The left graph displays the mean change in total symptom score from baseline, with Doxazosin showing a greater reduction than placebo. The right graph shows the mean increase in maximum urinary flow rate (mL/sec) from baseline, where Doxazosin exhibits a higher increase compared to placebo.*

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Doxazosin Tablets, USP 1 mg oral tablets label from Upsher-Smith Laboratories, LLC. The package contains 100 tablets and is labeled Rx only. The label includes NDC 0832-0356-11, storage instructions at controlled room temperature, and a child-resistant package warning. Barcode and manufacturer details are also visible.*

FDA Label Image

Principal Display Panel (2 mg Tablet Bottle Label)

Label for Doxazosin Tablets USP 2 mg oral tablets by Upsher-Smith Laboratories, LLC. The package contains 100 tablets. The label includes the NDC number 0832-0357-11, dosage strength, storage instructions, and barcode. It states 'Rx only' and provides distributor information.*

FDA Label Image

Principal Display Panel (4 mg Tablet Bottle Label)

Doxazosin Tablets, USP 4 mg oral tablet label from Upsher-Smith Laboratories, LLC. The label indicates 100 tablets per package and includes storage instructions, dosage reference, and child-resistant packaging details. The label features the NDC number 0832-1358-11 and a barcode.*

FDA Label Image

Principal Display Panel (8 mg Tablet Bottle Label)

Doxazosin Tablets USP 8 mg oral tablet label from Upsher-Smith Laboratories, LLC. The label indicates the package contains 100 tablets and includes regulatory and storage information with child-resistant packaging details. The label also displays the NDC 0832-1359-11 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.